DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steven Hoerter on Q1 2022 Results - Earnings Call Transcript
Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Margarida Duarte - SVP & Head, International Steven Hoerter - President, CEO & Director Daniel Martin - SVP & Chief Commercial Officer Matthew Sherman - EVP & Chief Medical Officer Thomas Kelly - EVP, CFO & Treasurer Conference Call Participants Daniel Wolle - JPMorgan Chase & Co. Eun Yang - Jefferies Allison Bratzel - Piper Sandler & Co. Paul Jeng - Guggenheim Securities Reni Benjamin - JMP Securities Andrew Berens - SVB Leerink Peter Lawson - Barclays Bank Bradley Canino - Stifel, Nicolaus & Company Maghan Meyers - SVP, Argot Partners Presentation Operator Good morning, everyone, and welcome to Deciphera Pharmaceuticals First Quarter 2022 Financial Results Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Maghan Meyers, Senior Vice President at Argot Partners. Maghan?
For further details see:
Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q1 2022 Results - Earnings Call Transcript